1. Home
  2. VANI
  3. VANI News

Latest Vivani Medical Inc. (DE) (VANI) News on April 2, 2025

VANI

Associated Press Finance

2 days ago

Vivani Medical: Q4 Earnings Snapshot

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
VANI

GlobeNewswire

2 days ago

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Vivani Medical Announces $8.25M Private Placement Equity Financing
VANI

GlobeNewswire

6 days ago

Vivani Medical Announces $8.25M Private Placement Equity Financing

Vivani Medical Gives Data for Weight Loss Implant
VANI

Exec Edge

7 days ago

Vivani Medical Gives Data for Weight Loss Implant

Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing
VANI

GlobeNewswire

7 days ago

Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing

EXCLUSIVE: Vivani Medical Subdermal Semaglutide Implant Shows 20% Weight Loss In Animal Study, With Potential For Once-Yearly Dosing
VANI

Benzinga

7 days ago

EXCLUSIVE: Vivani Medical Subdermal Semaglutide Implant Shows 20% Weight Loss In Animal Study, With Potential For Once-Yearly Dosing

Presenting on the Emerging Growth Conference 80 Day 2 on March 27 Register Now
VANI

GlobeNewswire

7 days ago

Presenting on the Emerging Growth Conference 80 Day 2 on March 27 Register Now

Vivani Medical to Present at the Emerging Growth Conference on March 27, 2025
VANI

Business Wire

9 days ago

Vivani Medical to Present at the Emerging Growth Conference on March 27, 2025

What Makes Vivani Medical (VANI) a New Buy Stock
VANI

Zacks

16 days ago

What Makes Vivani Medical (VANI) a New Buy Stock

Vivani Medical Achieves 1st Implant & Full Enrollment in Overweight Trial
VANI

Exec Edge

20 days ago

Vivani Medical Achieves 1st Implant & Full Enrollment in Overweight Trial

Vivani treats first patient with long-lasting drug implant for weight loss
VANI

Medical Device Network

20 days ago

Vivani treats first patient with long-lasting drug implant for weight loss

VANI

MT Newswires

20 days ago

Vivani Medical Completes Enrollment, Begins Dosing in Diabetes Implant Trial

Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults
VANI

Business Wire

20 days ago

Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults

EXCLUSIVE: Vivani Medical Announces First Implant In Early-Stage Human Study Of GLP-1 Implant For Obesity
VANI

Benzinga

20 days ago

EXCLUSIVE: Vivani Medical Announces First Implant In Early-Stage Human Study Of GLP-1 Implant For Obesity

Vivani to spin off neurostimulation business
VANI

MedTech Dive

20 days ago

Vivani to spin off neurostimulation business

Vivani Medical to Spin-Off Neurostimulation Division Cortigent for Nasdaq Listing
VANI

Exec Edge

21 days ago

Vivani Medical to Spin-Off Neurostimulation Division Cortigent for Nasdaq Listing

Vivani Medical to spin-off neurostim business Cortigent as public company
VANI

Medical Device Network

21 days ago

Vivani Medical to spin-off neurostim business Cortigent as public company

VANI

MT Newswires

21 days ago

Vivani Medical Plans to Spin Off Cortigent Neurostimulation Business

Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation Business
VANI

Business Wire

21 days ago

Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation Business

EXCLUSIVE: Vivani Medical To Spin Off Cortigent Neurostimulation Business To Create Better Focus On Individual Entities And Shareholder Value
VANI

Benzinga

21 days ago

EXCLUSIVE: Vivani Medical To Spin Off Cortigent Neurostimulation Business To Create Better Focus On Individual Entities And Shareholder Value

Presenting on the Emerging Growth Conference 78 Day 2 on January 16 Register Now
VANI

GlobeNewswire

3 months ago

Presenting on the Emerging Growth Conference 78 Day 2 on January 16 Register Now

Vivani begins exenatide implant trial for obesity in Australia
VANI

Medical Device Network

3 months ago

Vivani begins exenatide implant trial for obesity in Australia

Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia
VANI

Business Wire

3 months ago

Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

EXCLUSIVE: Vivani Medical Initiates First Human Clinical Trial With GLP-1 Implant For Weight Loss In Australia
VANI

Benzinga

3 months ago

EXCLUSIVE: Vivani Medical Initiates First Human Clinical Trial With GLP-1 Implant For Weight Loss In Australia

Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast
VANI

Business Wire

4 months ago

Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast

Independent Chairman of the Board of Vivani Medical Gregg Williams Buys 30% More Shares
VANI

Simply Wall St.

5 months ago

Independent Chairman of the Board of Vivani Medical Gregg Williams Buys 30% More Shares

VANI

Associated Press Finance

5 months ago

Vivani Medical: Q3 Earnings Snapshot

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results
VANI

Business Wire

5 months ago

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results

Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now
VANI

GlobeNewswire

5 months ago

Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now

3 US Penny Stocks To Monitor In October 2024
VANI

Simply Wall St.

5 months ago

3 US Penny Stocks To Monitor In October 2024

Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024
VANI

Business Wire

5 months ago

Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024

VANI

Argus Research

6 months ago

Daily – Vickers Top Buyers & Sellers for 10/04/2024

Vivani Medical obtains Australian approval to begin GLP-1 implant trial
VANI

Medical Device Network

6 months ago

Vivani Medical obtains Australian approval to begin GLP-1 implant trial

Vivani Medical to Test Implant in Obese and Overweight Patients
VANI

Exec Edge

6 months ago

Vivani Medical to Test Implant in Obese and Overweight Patients

Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia
VANI

Business Wire

6 months ago

Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

EXCLUSIVE: Vivani Medical Advances Its Obesity Treatment Implant With New Clinical Trial in Australia
VANI

Benzinga

6 months ago

EXCLUSIVE: Vivani Medical Advances Its Obesity Treatment Implant With New Clinical Trial in Australia

Presenting on the Emerging Growth Conference 75 Day 1 on September 25 Register Now
VANI

GlobeNewswire

6 months ago

Presenting on the Emerging Growth Conference 75 Day 1 on September 25 Register Now

Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024
VANI

Business Wire

6 months ago

Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024

Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant
VANI

Business Wire

7 months ago

Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant

EXCLUSIVE: Vivani Medical Reveals Positive Preclinical Liver Fat Results From Miniature GLP-1 Implant For Obesity
VANI

Benzinga

7 months ago

EXCLUSIVE: Vivani Medical Reveals Positive Preclinical Liver Fat Results From Miniature GLP-1 Implant For Obesity

Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
VANI

Business Wire

7 months ago

Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Here's Why We're Watching Vivani Medical's (NASDAQ:VANI) Cash Burn Situation
VANI

Simply Wall St.

8 months ago

Here's Why We're Watching Vivani Medical's (NASDAQ:VANI) Cash Burn Situation

VANI

Associated Press Finance

8 months ago

Vivani Medical: Q2 Earnings Snapshot

Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results
VANI

Business Wire

8 months ago

Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results

Vivani to start in-human trial for GLP-1 implant for treating obesity
VANI

Medical Device Network

9 months ago

Vivani to start in-human trial for GLP-1 implant for treating obesity

VANI

Business Wire

9 months ago

Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115

EXCLUSIVE: Vivani Medical Outlines Plans To Kickstart First Clinical Study For Miniature GLP-1 Obesity Implant Program This Year
VANI

Benzinga

9 months ago

EXCLUSIVE: Vivani Medical Outlines Plans To Kickstart First Clinical Study For Miniature GLP-1 Obesity Implant Program This Year

Vivani Medical Receives FDA Clearance for Trial of Type-2 Diabetes Mini-Implant
VANI

Exec Edge

10 months ago

Vivani Medical Receives FDA Clearance for Trial of Type-2 Diabetes Mini-Implant

VANI

MT Newswires

10 months ago

Vivani Medical Says US FDA Approved Investigational New Drug Application for Potential Type 2 Diabetes Treatment

EXCLUSIVE: Vivani Medical's Type 2 Diabetes Treatment NPM-119 Subdermal Implant's IND Gains FDA Clearance For Clinical Use (UPDATED)
VANI

Benzinga

10 months ago

EXCLUSIVE: Vivani Medical's Type 2 Diabetes Treatment NPM-119 Subdermal Implant's IND Gains FDA Clearance For Clinical Use (UPDATED)

Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant
VANI

Business Wire

10 months ago

Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant

Insider Stock Buying Reaches US$751.8k On Vivani Medical
VANI

Simply Wall St.

10 months ago

Insider Stock Buying Reaches US$751.8k On Vivani Medical

EXCLUSIVE: Vivani Medical Highlights Weight Loss Data For GLP-1 Implant Supporting Potential Veterinary Use
VANI

Benzinga

10 months ago

EXCLUSIVE: Vivani Medical Highlights Weight Loss Data For GLP-1 Implant Supporting Potential Veterinary Use

Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant
VANI

Business Wire

10 months ago

Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant

VANI

Associated Press Finance

a year ago

Vivani Medical: Q1 Earnings Snapshot

Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results
VANI

Business Wire

a year ago

Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results

Vivani Medical to Present at TIDES Conference 2024
VANI

Business Wire

a year ago

Vivani Medical to Present at TIDES Conference 2024

VANI

GuruFocus.com

a year ago

Vivani Medical Inc (VANI) Reports Fourth Quarter and Full Year 2023 Financial Results

VANI

Associated Press Finance

a year ago

Vivani Medical: Q4 Earnings Snapshot

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
VANI

Business Wire

a year ago

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

VANI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 03/18/2024

VANI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 03/15/2024

VANI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 03/14/2024

VANI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 03/13/2024

VANI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 03/12/2024

VANI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 03/11/2024

VANI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 03/08/2024

VANI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 03/07/2024

Vivani Medical Appoints Daniel Bradbury to its Board of Directors
VANI

Business Wire

a year ago

Vivani Medical Appoints Daniel Bradbury to its Board of Directors

VANI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 03/06/2024

VANI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 03/05/2024

VANI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 03/04/2024

VANI

Business Wire

a year ago

Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants

VANI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 03/01/2024

Individual investors invested in Vivani Medical, Inc. (NASDAQ:VANI) up 287% last week, insiders too were rewarded
VANI

Simply Wall St.

a year ago

Individual investors invested in Vivani Medical, Inc. (NASDAQ:VANI) up 287% last week, insiders too were rewarded

VANI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 02/29/2024

EXCLUSIVE: Vivani Medical Says Weight Loss/Diabetes Implant At Par With Novo Nordisk's Famed Injectable Wegovy/Ozempic, Animal Studies Shows
VANI

Benzinga

a year ago

EXCLUSIVE: Vivani Medical Says Weight Loss/Diabetes Implant At Par With Novo Nordisk's Famed Injectable Wegovy/Ozempic, Animal Studies Shows

Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic®/Wegovy® and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio
VANI

Business Wire

a year ago

Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic®/Wegovy® and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio

VANI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 02/28/2024

VANI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 02/27/2024

VANI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 02/26/2024

VANI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 02/23/2024

VANI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 02/22/2024

VANI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 02/21/2024

VANI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 02/20/2024

VANI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 02/16/2024

VANI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 02/14/2024

VANI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 02/13/2024

VANI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 02/12/2024

VANI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 02/09/2024

VANI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 02/08/2024

VANI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 02/07/2024

VANI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 02/06/2024

BEN Launches New AI Assistants for Automotive Industry, Goes to Market as BENAuto for NADA Debut
VANI

Business Wire

a year ago

BEN Launches New AI Assistants for Automotive Industry, Goes to Market as BENAuto for NADA Debut

Catalyst Bancorp, Inc. Announces 2023 Fourth Quarter Results
VANI

PR Newswire

a year ago

Catalyst Bancorp, Inc. Announces 2023 Fourth Quarter Results

Clene VISIONARY-MS Trial Data May Support CNM-Au8(R) as MS Treatment
VANI

NewMediaWire

a year ago

Clene VISIONARY-MS Trial Data May Support CNM-Au8(R) as MS Treatment

VANI

ACCESSWIRE

a year ago

Monogram Orthopaedics to Present at the Canaccord Genuity Musculoskeletal Conference on February 12, 2024

Chuck Royce's Strategic Reduction in Graham Corp Holdings
VANI

GuruFocus.com

a year ago

Chuck Royce's Strategic Reduction in Graham Corp Holdings

Shareholders in Lifetime Brands (NASDAQ:LCUT) are in the red if they invested three years ago
VANI

Simply Wall St.

a year ago

Shareholders in Lifetime Brands (NASDAQ:LCUT) are in the red if they invested three years ago

D-Wave Becomes First Full-Stack Quantum Provider to Achieve SOC 2 Type 2 Compliance
VANI

NewMediaWire

a year ago

D-Wave Becomes First Full-Stack Quantum Provider to Achieve SOC 2 Type 2 Compliance

Share on Social Networks: